Shiyu Wang

Also affiliated with Yantai University, Hunan Cancer Hospital, Nanjing University, Delft University of Technology

EnergyEngineeringMaterials ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Utility of the 70-gene MammaPrint assay for prediction of benefit from extended letrozole therapy (ELT) in the NRG Oncology/NSABP B-42 trial.”.

Utility of the 70-gene MammaPrint assay for prediction of benefit from extended letrozole therapy (ELT) in the NRG Oncology/NSABP B-42 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.502

N/A

0DataRank · unranked

16 citations

Hanna Bandos, Peter C. Lucas, L. J. van ‘t Veer, Jia-Perng Jennifer Wei, Charles E. Geyer +15 more

Whole transcriptomic analysis of HR+ breast cancer in Black women classified as basal-type by BluePrint.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.517

N/A

0DataRank · unranked

2 citations

Tuya Pal, Xiao‐Ou Shu, Ann Tezak, Kent Hoskins, Dipali Sharma +9 more

CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.18.689150

N/A

0DataRank · unranked

0 citations

Shiyu Wang, Loan Duong, Ziyu Zeng, Jing Yang, Yun Zhao +9 more